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Mitragyna speciosa Korth, or better known as ketum, has long been used by traditional
folk around Southeast Asia to prevent fatigue from working under hot tropical weather
and as a replacement of opium, which can then cause addiction. To date, no findings
have been reported of the toxic effect of ketum subchronically (28 days). Hence, the
aim of this study was to investigate the toxicity of subchronic effect of standardized
methanolic extract of ketum (SMEMS) in Sprague-Dawley rats. Rats were orally
administered with 100, 200, and 500mg/kg of SMEMS for 28 days. Body weights
were recorded daily. They were terminated at day 28 to obtain data for hematology,
biochemistry, and histopathology of the brain, liver, kidney, lung, heart, sciatic nerve, and
spinal cord. The SMEMS affected body weight compared to control group. Biochemistry
findings showed that liver and kidney were affected with the abnormal values in AST,
creatinine, globulin, glucose, total protein, and urea. However, SMEMS produced toxic
effect more to liver, kidney, and lung than other organs as observed histopathologically.
The results suggested subchronic exposure of ketum is toxic to the physiology of the
animals.
Keywords: standardized methanolic extract, Mitragyna speciosa, subchronic toxicity, oral administration,
Sprague-Dawley rats
Introduction
Mitragyna speciosa Korth, or known as ketum, in Malaysia belongs to Rubiaeceae (Idid et al.,
1998), a coffee family. Ketum is an indigenous plant of Thailand and northern penisular Malaysia
used traditionally in folk medicine, although it has been reported to cause addiction (Chittrakarn
et al., 2008). Ketum has been traditionally used in Malaysia and Thailand as medicinal substance.
Originally, local people used it to alleviate pain, coughing, or diarrhea. It is also used to prevent
fatigue (Suwanlert, 1975). The leaf has been used in Thailand for its opium-like effect (Burkill et al.,
1935). In addition to being used in its own right, it is often used to replace opium when opium is
not available.
It was evidenced that mitragynine, the main alkaloid of ketum, at the cellukar level inhibits
neurotransmitter release from the nerve endings of vas deferens, partly through the blockade of
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neuronal Ca2+ channels (Matsumoto et al., 2005). It is postulated
that neuronal Ca2+ channel-blocking effect of mitragynine is the
mainmechanism for the analgesic and several other physiological
actions of mitragynine. Other action, mitragynine was shown to
inhibit forskolin-stimulated cAMP formation in NG108-15 cells
in vitro (Tohda et al., 1997). Physiologically, ketum has shown
to have antinociceptive, anti-inflammatory, gastrointestinal, and
neurophysiological effects (Kumarnsit et al., 2006; Mossadeq
et al., 2009; Idayu et al., 2011).
Acute administration of alkaloid extract of ketum significantly
resulted in dose-dependent decreases in food and water intake in
rats. Furthermore, prolonged suppressing effects were observed
following administration of the ketum extract for 60 days and also
significantly suppressed weight gaining (Kumarnsit et al., 2006).
Standardised methanolic extract of ketum has been reported to
increase blood pressure after an hour of administration. High
dose of the extract also induced acute severe hepatotoxicity
and mild nephrotoxicity. However, the extract has no effect on
body weight, food and water consumption, absolute and relative
organ weight, and hematology test (Harizal et al., 2010). The
present study was designed to determine the toxic effects of
standardized methanolic extract ofMitragyna speciosa (SMEMS)
in subchronic exposure to the body to add to the information on
period-influence exposure to the rodents.
Materials and Methods
Plant Material
Leaves of this species were collected from natural sources in
Jengka, Pahang, Malaysia. The identification of this species was
done by Forest Research Institute Malaysia (FRIM) and kept
in Universiti Sains Malaysia (USM) herbarium with voucher
number USM 11074. This plant was restricted to research
purposes only.
Mitragyna Speciosa Korth Methanolic Extraction
and Standardization
The leaves of the plant were collected and thoroughly washed
with distilled water to remove the dirt. The wet leaves were
weighed and then dried in an oven at 50◦C for 12 h. During
this time, the leaves were periodically turned over to provide
uniform drying. The dried leaves were ground to fine powder
by a mill machine and the powder was weighed. Then, 100 g
of the powder was exhaustively soxhlet extracted in methanol
(100% v/v) by using an extractor and condenser (Ace Soxhlet
Extractor 6730, Condenser 6740, Quick Fit, England) for 4 h
at 60◦C. Next, the extract was concentrated under reduced
pressure at 40◦C using a rotary evaporator. Then, it was further
concentrated by allowing it to stand overnight in an oven
at 30◦C to remove any trace of methanol. The final product
yielded 20 g of a dark green extract which was then screened
for the presence of the alkaloid mitragynine using GC-MS. The
extract produced was standardized with reference to the amount
of mitragynine content using validated GC-MS method. Dried
extract was stored at 4◦C until further use (Amresh et al.,
2007).
Animals
Adult male Sprague-Dawley rats were weighing 50–60 g and aged
4 weeks were obtained from the breeding colony of the Animal
Research and Service Centre (ARASC) USM. The animals were
fed with standard commercial food pellets and water ad libitum.
They were housed in a temperature-controlled room at 25± 2◦C
with a relative humidity of 50 ± 5% and a 12 h light/12 h dark
cycle. All the experiments were performed with the approval of
Animal Ethics Committee of USM.
Drugs Administration
SMEMS was suspended in distilled water homogenously to
act as a vehicle. Six rats per group were administered with
100 (MS100), 200 (MS200), and 500 (MS500)mg/kg in each
group while the control group received distilled water. Rats
underwent administration for 28 days daily via oral route
(OECD, 2008). Body weight was recorded daily starting from the
1 day administration until the end.
Specimen Collection
On the last day (day 28), the rats from each group were
anesthetised by chloroform, and the blood was taken using
cardiac puncture procedure. Some of the blood collected was put
in a plastic test tube containing anticoagulant EDTA and some
part used for serum collection (biochemical analyses). Then, the
rats were decapitated (termination) by guillotine and dissected to
obtain brain, lung, heart, kidney, liver, sciatic nerve, and spinal
cord for histology purposes.
Biochemical Analysis
The blood samples that were collected during termination were
centrifuged at 3000 rpm for 15min to collect the serum. The
serum samples then were aspirated off and frozen at −80◦C.
They were analyzed for the determination of albumin, alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
cholesterol, creatinine, glucose, phosphate, globulin, urea, total
protein, and lactate dehydrogenase (LDH). Biochemical analyses
were carried out with an automatic chemistry analyser (Hitachi
902, Japan; Reagent by ROCHE Diagnostic GmbH, Germany).
Haematology
The blood samples that were collected underwent blood count
using the automatic hematology system (BC-3000 Plus, Mindray,
Shenzhen, China) to evaluate red blood cell (RBC), white blood
cell (WBC), hemoglobin (HGB), haematocrit (HCT), mean
corpuscular volume (MCV), mean corpuscular hemoglobin
(MCH), mean corpuscular hemoglobin concentration (MCHC),
and platelet (PLT).
Histopathology
Tissue Preparation
The method of tissue preparation was adapted from Jain et al.
(2008). The tissues obtained during the termination process were
fixed in 10% formalin, dehydrated in gradual ethanol (50–100%).
After that, the tissues were cleared using xylene and embedded in
paraffin. The process continued with the sectioning process. All
tissues were sectioned with 5µm of thickness using microtome
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and transferred into a 40◦C water bath for fishing process. The
sections were fished by glass slides and then allowed to dry on the
slide warmer.
Haematoxylin and Eosin (H&E) Staining
The H&E staining protocol followed a standard protocol of the
Department of Pathology, USM. The staining process was started
by soaking the sections in xylene twice for 2min each. The
process continued by soaking in absolute alcohol, 90% and 80%
alcohol for 2min each. Then, the slides were rinsed with tap
water and were soaked in haematoxylin for 20min. After that,
the slides were rinsed again under running tap water. Then, they
were dipped in acid alcohol for 3 s andwere rinsed again for 5min
under tap water. Next, the slides were dipped in ammonia water
for 10 s and rinsed for 2min. The slides were then soaked in eosin
for 2min. The process continued by soaking the slides in 80, 90%,
and absolute alcohol for 2min each. The last step was soaking the
slides in xylene twice for 2min each. The sections were covered
by cover slip and observed under microscope.
Statistical Analyses
Statistical analysis for body weight data was done by repeated
measure ANOVA while Tukey’s test was used for the post-
hoc test. For hematology and biochemical analysis, data were
analyzed using One-Way ANOVA. Differences between groups
were considered significant if p < 0.05. All data points show the
mean of standard error means (SEM).
Results
Body Weight Measurement
Subchronic exposure of SMEMS showed average body weight
gains for MS100, MS200, and MS500 were 6.6, 7.9, and 5.2 g/day,
respectively, compared to control of 7.8 g/day.MS500 showed the
lowest weight gain compared to other dose regime groups and
also the control group. There were significant differences between
MS200 and other groups (p < 0.01, except for MS500 which
p < 0.001).
Biochemical Analyses
Biochemistry data in Table 1 some of the parameters such as
AST, creatinine, globulin, glucose, total protein, and urea showed
significant differences when compared to respective group.
Group MS100 differed significantly when compared to control
group with p < 0.05 for AST.MS500 recorded significantly lower
than MS100 for AST parameter. MS 200 and MS500 recorded
significant differences in creatinine reading compared to the
control group with p < 0.05 and p < 0.01, respectively. Among
the groups, only MS200 recorded significantly high globulin
readings compared to the control group with p < 0.05. In
glucose, MS200 and MS500 were significantly higher than in
the control group with p < 0.05. Total protein reading in
MS200 was significantly higher than the control with p < 0.05.
Lastly, both MS200 and MS500 showed significant differences
in urea parameter when compared to both control and MS100
groups.
Haematology
Haematology results show that none of the groups differ
significantly when compared to control for all parameters. Data
presented were analyzed by using One-Way ANOVA test. The
details are shown in Table 2.
Histopathology
Histopathology results showed that brain, heart, spinal cord, and
sciatic nerve were not affected by the subchronic exposure to
SMEMS for all the doses when compared to normal. There were
no abnormalities observed in the histopathology slides. However,
the other organs such as liver, lung, and kidney were affected
by SMEMS, as shown in Figure 1. Doses of 200 and 500mg/kg
affected kidney, liver, and lung significantly compared to the
lowest dose and the vehicle group.
Discussion
M. speciosa has long been used in treating illnesses traditionally.
The present study has been conducted to gather information
on the toxic effects of the subchronic consumption of the
plant. Animals were exposed to SMEMS for 28 days via
oral route. Throughout the administrations, daily body weight
measurements were taken. On day 28, animals were euthanised
to obtain blood and organs for biochemistry, hematology,
and histopathology analyses. Dosages were justified based on
previous study by Reanmongkol et al. (2007) that proved dose
100mg/kg methanolic extract of ketum showed significant effect
toward nociceptive response acutely. Thus, in this subchronic
study we tested the same dose and increased to 200 and
500mg/kg.
Animals in the group MS100 and MS500 showed significant
body weight loss compared to the control group, while MS200
showed similarity in body weight gain compared to the
control group. Kumarnsit et al. (2006) reported that ketum
extract suppressed weight gain after 60 days of administration.
Chittrakarn et al. (2008) documented ketum extract decreased
the increment of body weight at doses of 200 and 400mg/kg
after 30 days of exposure. Mitragynine, the main biocompound
of ketum, exerted an inhibitory effect on gastric acid secretion
through opioid receptors. There is a probability that the
mechanism of side effects such as anorexia and weight loss
induced by mitragynine is related to the inhibitory effect on
gastric acid secretion (Tsuchiya et al., 2002). Sabetghadam et al.
(2013) reported a significant increase in the relative body weight
of male rats treated with 28-day 1mg/kg mitragynine. However,
female rats treated with 28 days 100mg/kg mitragynine recorded
body weight decrease. Thus, high dose of ketum extract might
affect the appetite at subchronic exposure.
This study also investigated biochemical analysis of the serum.
Liver-related biochemicals such as AST, total bilirubin, and
glucose in the present study showed statistically significant
differences when compared to the control group. Our findings
showed that the AST reading was significantly lower in rats
that received the highest dose of ketum compared to rats
that received the lowest dose of ketum. Significant differences
were also observed between MS100 and control group. AST is
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TABLE 1 | Biochemistry data of rats after subchronic administrations of SMEMS.
Parameter Control (n = 6) MS100 (n = 6) MS200 (n = 6) MS500 (n = 6)
Albumin (g/l) 33.67±0.422 34.50± 0.671 36.83± 1.302 35.50±0.563
ALT (IU/L) 56.00±1.862 85.33± 17.653 72.40± 7.325 61.00±2.683
AST (IU/L) 156.33±10.607 303.50± 55.438# 215.80± 19.368 100.50±4.080∅∅
Cholesterol (mmol/l) 1.61±0.045 1.59± 1.10g 1.51± 0.132 1.46±0.948
Creatinine (µmol/L) 49.50±0.619 58.83± 1.108 63.17± 4.629# 65.00±3.493##
Globulin (g/L) 30.50±1.285 32.50± 1.177 40.17± 4.254# 35.50±1.057
Glucose (mmol/l) 6.52±0.294 7.47± 0.306 8.37± 0.390# 8.20±0.218#
Phosphate (mmol/l) 2.56±0.058 2.72± 0.092 2.87± 0.075 2.67±0.081
LDH (mmol/l) 2471.67±389.186 2189.33± 431.132 2587.20± 242.563 2650.83±325.367
T. Protein (g/l) 64.17±1.046 67.00± 1.366 77.00± 5.532# 69.60±1.033
Urea (mmol/l) 6.967±0.150 7.60± 0.348 9.23± 0.504#∅ 9.30±0.480#∅
Data indicate mean ± SEM.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase.
#Statistically significant different compared to control, p < 0.05;
##Statistically significant different compared to control, p < 0.01;
∅Statistically significant different compared to MS100, p < 0.05;
∅∅Statistically significant different compared to MS100, p < 0.01.
TABLE 2 | Haematology data of rats after subchronic administration of SMMSE.
Parameter Control (n = 6) MS100 (n = 6) MS200 (n = 6) MS500 (n = 6)
White Blood Cell (× 109/L) 6.70± 0.071 7.23± 0.680 6.44± 0.745 6.03±1.492
Haemoglobin (g/L) 14.34± 0.300 14.55± 0.393 15.38± 0.421 15.43±0.259
Red Blood Cell (× 1012/L) 7.35± 0.140 7.36± 0.396 7.72± 0.336 7.62±0.230
Haematocrit (L/L) 40.48± 0.876 40.86± 1.228 43.06± 1.421 43.05±0.620
MCV (fL) 55.24± 1.490 55.93± 1.375 55.90± 0.719 56.78±1.975
MCH (g/L) 19.48± 0.517 19.85± 0.552 19.92± 0.332 20.23±0.453
MCHC (g/L) 35.38± 0.287 35.58± 0.125 35.70± 0.190 35.80±0.549
Platelet (× 109/L) 728.00± 70.379 907.00± 6.285 829.00± 46.242 850.50±49.769
Data indicate mean ± SEM.
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration.
one of the transaminases that are useful in evaluating muscle
and liver damage in small and large animals. Its levels are
expected to be less in the state of necrosis, as observed in
the histopathology part of the present study. The findings
showed that the level of creatinine in the groups MS200 and
MS500 were higher significantly compared to that of the control
group. Data from an acute toxicity study of ketum (dose
of 1000mg/kg) showed similar findings to the present study
(Harizal et al., 2010). This biochemistry data was paralleled
to our finding of kidney histopathology discussed below. The
increase in serum creatinine demonstrates that the filtration
process of the kidneys is deficient. Opioids such as morphine
have been reported to cause renal damage by increasing the
creatinine level (Atici et al., 2005). Another indicator of renal
damage is the increase in the blood urea parameter. In the
present study, the data show a high level of blood urea in
MS200 and MS500 groups compared to that of control and
MS100 groups. The findings also showed similarity to the acute
toxicity study of ketum in Sprague-Dawley rats (Harizal et al.,
2010) and rats treated with morphine chronically (Atici et al.,
2005). Thus, M. speciosa, which possesses an opioid-like effect,
is believed through chronic exposure to impair renal function or
cause nephrotoxicity. Globulin was observed to be high in rats
receiving 200mg/kg ketum differed significantly from control.
Globulins are important plasma proteins primarily associated
with antibodies. Mitragynine showed significant increases in
LDH, ALT, AST, and urea after being treated daily for 28 days
with a subchronic dose of 100mg/kg (Sabetghadam et al., 2013).
This shows that the extract is toxic to the blood and might trigger
the immune system to react toward that toxicity.
Subchronic administration of SMEMS not only caused
damage to the liver as occurred in the acute toxicity studies
of ketum from the histopathological data (Harizal et al., 2010;
Kamal et al., 2012), but also caused damage to kidneys and lungs.
At all doses, M. speciosa showed toxic effects for liver, kidneys
and lungs. The observation byH&E staining showed the presence
of blood vessels and neutrophils in MS500, portal inflammation,
interphase necrosis, and bile duct proliferation in MS200 in
the liver. Rats treated with chronic morphine suffered liver
damage caused by focal vacuolar (fatty changes) degenerative
change, with mononuclear cell infiltration in the hepatocytes
(Sumathi and Niranjali Devaraj, 2009). Mild congestion of
kidney blood vessels was also observed in MS100 and MS200.
However, blood vessel congestion was nearly moderate inMS500.
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FIGURE 1 | Histopathology slides of affected organs after subchronic
exposure to SMEMS. (A) Kidney section from control (10X). (B) Hydropic
degeneration present at the kidney’s cortex of MS200 (20X). (C) Hydropic
degeneration (HD) present at the kidney’s medulla of MS500 (20X). (D) Liver
section from control (10X). (E) Section of liver showing bile duct proliferation
BD (20X). (F) Section of liver showing the presence of neurtrophil (N) from
exposed group (20X). (G) Lung section from control (20X). (H) Section of lung
showing emphysema (20X).
Hydropic degeneration was seen in the medulla and cortex
regions of the kidney for MS100 and MS200, respectively. In
MS500, hydropic degeneration was seen in both medulla and
cortex regions. The effect of chronic morphine intoxication on
rat kidneys showed mild tubular epithelial cell degeneration
with cellular casts within the lumen of the tubules (Sumathi
and Niranjali Devaraj, 2009). These effects of ketum extract on
liver and kidney were similar to the effects of morphine (Atici
et al., 2005). SMEMS exposed subchronically affected lungs by
causing emphysema and the over-inflation of the alveoli. We
believed that chemicals from the extract trapped in the alveoli
later caused the inflammatory response, which will cause the
alveolar septum to disintegrate known as septal rupture. Septal
rupture leads to significant deformations of lung architecture
(Nazari, 2002). Our unpublished data showed that SMEMS had
fully blocked the long-term potentiation(LTP) in the same group
of rat’s hippocampal slices after subchronic exposure despite
histopathology findings of the brain that did not show any
apparent morphological changes. Li et al. (2012) reported that,
long-term potentiation was impaired in xCT-deficient sut mice
although no morphological changes were observed in the brain
specimens stained with H&E and examined under the electron
microscope. We speculate that the dosages applied in our
experiments were insufficient to cause morphological alterations
in the brain despite exhibiting changes in LTP.
In several parameters, the middle dose which is 200mg/kg
showed whether it was the highest or the lowest in giving such
effects to certain results. This phenomenon can be explained
as the hormetic response or U-shaped response. The hormetic
response would reflect a decrease in the incidence of an adverse
response such as disease/injury at low dose and an increase at
higher dose (Calabrese and Baldwin, 2001).
Conclusion
In conclusion, M. speciosa Korth is toxic to the rat upon
subchronic exposure of 28 days. This toxicity can affect
body weight, behavior, organs such as liver, kidney and
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lung and the blood. Generally, the higher doses in both
MS200 and MS500 affected most of the parameters. Data
from biochemical analyses and histopathology support each
other and demonstrate that the plant is such an intoxicant
material. The present study provides information primarily on
whole-body toxicity effects at the subchronic level. Further
study should be undertaken to seek the effect of chronic
exposure to this plant in order to understand its potential for
human use.
Acknowledgments
This is to acknowledge a short-term grant from the School of
Medical Sciences, Universiti SainsMalaysia (304/PPSP/6131429).
References
Amresh, G., Singh, P. N., and Rao, C. H. V. (2007). Antinociceptive and
antiarthritic activity of Cissampelos paraira roots. J. Ethnopharmacol. 111,
531–536. doi: 10.1016/j.jep.2006.12.026
Atici, S., Cinel, I., Cinel, L., Doruk, N., Eskandari, G., andOral, U. (2005). Liver and
kidney toxicity in chronic use of opioids: an experimental long term treatment
model. J. Biosci. 30, 245–252. doi: 10.1007/BF02703705
Burkill, I. H., Birtwistle, W., Foxworthy, F. W., Scrivenor, J. B., and Watson,
J. G. (1935). A Dictionary of the Economic Products of the Malay
Peninsula, London: Published on behalf of the governments of the Straits
settlements and Federated Malay states by the Crown agents for the colonies.
Calabrese, E. J., and Baldwin, L. A. (2001). U-shaped Dose-responses in biology,
toxicology, and public health 1. Annu. Rev. Public Health 22, 15–33. doi:
10.1146/annurev.publhealth.22.1.15
Chittrakarn, S., Sawangjaroen, K., Prasettho, S., Janchawee, B., and Keawpradub,
N. (2008). Inhibitory effects of kratom leaf extract (Mitragyna speciosa
Korth.) on the rat gastrointestinal tract. J. Ethnopharmacol. 116, 173–178. doi:
10.1016/j.jep.2007.11.032
Harizal, S., Mansor, S., Hasnan, J., Tharakan, J., and Abdullah, J. (2010).
Acute toxicity study of the standardized methanolic extract of Mitragyna
speciosa Korth in rodent. J. Ethnopharmacol. 131, 404–409. doi:
10.1016/j.jep.2010.07.013
Idayu, N. F., Hidayat, M. T., Moklas, M., Sharida, F., Raudzah, A. N., Shamima, A.,
et al. (2011). Antidepressant-like effect of mitragynine isolated fromMitragyna
speciosa Korth in mice model of depression. Phytomedicine 18, 402–407. doi:
10.1016/j.phymed.2010.08.011
Idid, S., Saad, L., Yaacob, H., and Shahimi, M. (1998). Evaluation of analgesia
induced by mitragynine, morphine and paracetamol on mice. ASEAN Rev.
Biodivers. Environ. Conserv. Article 4, 1–7.
Jain, A., Soni, M., Deb, L., Rout, S., Gupta, V., and Krishna, K. (2008).
Antioxidant and hepatoprotective activity of ethanolic and aqueous extracts
of Momordica dioica Roxb. leaves. J. Ethnopharmacol. 115, 61–66. doi:
10.1016/j.jep.2007.09.009
Kamal, M. S. A., Ghazali, A. R., Yahya, N. A., Wasiman, M. I., and Ismail, Z. (2012).
Acute Toxicity Study of Standardized Mitragyna speciosa Korth Aqueous
Extract in Sprague Dawley Rats. J. Plant Stud. 1, 120. doi: 10.5539/jps.v1n2p120
Kumarnsit, E., Keawpradub, N., and Nuankaew, W. (2006). Acute and long-term
effects of alkaloid extract of Mitragyna speciosa on food and water intake and
body weight in rats. Fitoterapia 77, 339–345. doi: 10.1016/j.fitote.2006.04.006
Li, Y., Tan, Z., Li, Z., Sun, Z., Duan, S., and Li, W. (2012). Impaired long-term
potentiation and long-term memory deficits in xCT-deficient sut mice. Biosci.
Rep. 32, 315–321. doi: 10.1042/BSR20110107
Matsumoto, K., Yamamoto, L. T., Watanabe, K., Yano, S., Shan, J., Pang, P. K. T.,
et al. (2005). Inhibitory effect of mitragynine, an analgesic alkaloid from Thai
herbal medicine, on neurogenic contraction of the vas deferens. Life Sci. 78,
187–194. doi: 10.1016/j.lfs.2005.04.042
Mossadeq, W. S., Sulaiman, M., Mohamad, T. T., Chiong, H., Zakaria, Z., Jabit,
M., et al. (2009). Anti-inflammatory and antinociceptive effects of Mitragyna
speciosa Korth methanolic extract. Med. Princi. Pract. 18, 378–384. doi:
10.1159/000226292
Nazari, S. (2002). Mechanical events in physiopathology of idiopathic pulmonary
emphysema: a theoretical analysis. Internet J. Thorac. Cardiovasc. Surg. 5.
OECD. (2008). “Repeated Dose 28-day oral toxicity study in Rodents” in OECD
Guidelines for the Testing of Chemicals, Section 4 (Pairs: OECD Publishing). doi:
10.1787/9789264070684-en
Reanmongkol, W., Keawpradub, N., and Sawangjaroen, K. (2007). Effects of the
extracts from Mitragyna speciosa Korth. leaves on analgesic and behavioral
activities in experimental animals. Songklanakarin J. Sci. Technol. 29(Suppl. 1),
39–48.
Sabetghadam, A., Ramanathan, S., Sasidharan, S., and Mansor, S. M.
(2013). Subchronic exposure to mitragynine, the principal alkaloid
of Mitragyna Speciosa, in rats. J. Ethnopharmacol. 146, 815–823. doi:
10.1016/j.jep.2013.02.008
Sumathi, T., and Niranjali Devaraj, S. (2009). Effect of Bacopa monniera on liver
and kidney toxicity in chronic use of opioids. Phytomedicine 16, 897. doi:
10.1016/j.phymed.2009.03.005
Suwanlert, S. (1975). A study of kratom eaters in Thailand. Bull. Narc. 27, 21–27.
Tohda, M., Thongpraditchote, S., Matsumoto, K., Murakami, Y., Sakai, S.-I., Aimi,
N., et al. (1997). Effects of mitragynine on cAMP formation mediated by
delta-opiate receptors in NG108-15 cells. Biol. Pharm. Bull. 20, 338–340.
Tsuchiya, S., Miyashita, S., Yamamoto, M., Horie, S., Sakai, S. I., Aimi, N., et al.
(2002). Effect of mitragynine, derived from Thai folk medicine, on gastric acid
secretion through opioid receptor in anesthetized rats. Eur. J. Pharmacol. 443,
185–188. doi: 10.1016/S0014-2999(02)01588-1
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Ilmie, Jaafar, Mansor and Abdullah. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 6 June 2015 | Volume 9 | Article 189
